Effect of Denosumab on Peripheral Compartmental Bone Density, Microarchitecture and Estimated Bone Strength in De Novo Kidney Transplant Recipients

Background/Aims: In a randomized controlled clinical trial in kidney transplant recipients (NCT01377467) we have recently shown that RANKL inhibition with denosumab significantly improved areal bone mineral density (aBMD) when given during the first year after transplantation. The effect of denosuma...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Marco Bonani, Ursina Meyer, Diana Frey, Nicole Graf, Heike A. Bischoff-Ferrari, Rudolf P. Wüthrich
Formato: Artigo
Idioma:Inglês
Publicado em: Karger Publishers 2016-09-01
coleção:Kidney & Blood Pressure Research
Assuntos:
Dual energy X-ray absorptiometry (DXA)
Denosumab
High-resolution peripheral quantitative computed tomography (HRpQCT)
Kidney transplantation
Osteoporosis
Acesso em linha:http://www.karger.com/Article/FullText/447930
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados